
Cell therapy company dedicated to improving the lives of patients with rare diseases.
Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells. The company is developing a technology platform called Immune System Programming (ISP™), which modifies a patient’s B cells and instructs them to produce gene-encoded medicines. The B cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients and provide therapeutic benefit for many years. The company is based in Seattle, WA.
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
Frequently Asked Questions
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.